-
1
-
-
0028158243
-
Nomenclature of systemic vasculitides: Proposal of an international consensus conference
-
Jennette JC, et al. (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 37:187-92.
-
(1994)
Arthritis Rheum
, vol.37
, pp. 187-192
-
-
Jennette, J.C.1
-
2
-
-
63149095577
-
Progress of treatment in ANCAassociated vasculitis (Review)
-
Jayne D. (2009) Progress of treatment in ANCAassociated vasculitis (Review). Nephrology (Carlton) 14:42-8.
-
(2009)
Nephrology (Carlton)
, vol.14
, pp. 42-48
-
-
Jayne, D.1
-
3
-
-
25444502877
-
Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production
-
Voswinkel J, Muller A, Lamprecht P. (2005) Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Ann. N. Y. Acad. Sci. 1051:12-9.
-
(2005)
Ann. N. Y. Acad. Sci
, vol.1051
, pp. 12-19
-
-
Voswinkel, J.1
Muller, A.2
Lamprecht, P.3
-
4
-
-
0036790387
-
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
-
Xiao H, et al. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 110:955-63.
-
(2002)
J. Clin. Invest
, vol.110
, pp. 955-963
-
-
Xiao, H.1
-
5
-
-
24744445377
-
Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo
-
Little MA, et al. (2005) Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 15:2050-8.
-
(2005)
Blood
, vol.15
, pp. 2050-2058
-
-
Little, M.A.1
-
6
-
-
0036623121
-
Wegener's granulomatosis: Antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release-role of autocrine cell activation
-
Hattar K, et al. (2002) Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release-role of autocrine cell activation. J. Leukoc. Biol. 71:996-1004.
-
(2002)
J. Leukoc. Biol
, vol.71
, pp. 996-1004
-
-
Hattar, K.1
-
7
-
-
0024584528
-
Specific recognition of cruciform DNA by nuclear protein HMG1
-
Bianchi ME, Beltrame M, Paonessa G. (1989) Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243:1056-9.
-
(1989)
Science
, vol.243
, pp. 1056-1059
-
-
Bianchi, M.E.1
Beltrame, M.2
Paonessa, G.3
-
8
-
-
0034252817
-
Upwardly mobile proteins. Workshop: The role of HMG proteins in chromatin structure, gene expression and neoplasia
-
Bianchi ME, Beltrame M. (2000) Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep. 1:109-14.
-
(2000)
EMBO Rep
, vol.1
, pp. 109-114
-
-
Bianchi, M.E.1
Beltrame, M.2
-
9
-
-
17144376810
-
High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal
-
Lotze MT, Tracey KJ. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331-42.
-
(2005)
Nat. Rev. Immunol
, vol.5
, pp. 331-342
-
-
Lotze, M.T.1
Tracey, K.J.2
-
10
-
-
0033538467
-
HMG-1 as a late mediator of endotoxin lethality in mice
-
Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-51.
-
(1999)
Science
, vol.285
, pp. 248-251
-
-
Wang, H.1
-
11
-
-
1542316768
-
Extra cellular role of HMGB1 in inflammation and sepsis
-
Wang H, Yang H, Tracey KJ. (2004) Extra cellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255:320-31.
-
(2004)
J. Intern. Med
, vol.255
, pp. 320-331
-
-
Wang, H.1
Yang, H.2
Tracey, K.J.3
-
12
-
-
0037062934
-
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
-
Scaffidi P, Misteli T, Bianchi ME. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-5.
-
(2002)
Nature
, vol.418
, pp. 191-195
-
-
Scaffidi, P.1
Misteli, T.2
Bianchi, M.E.3
-
13
-
-
0034698830
-
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes
-
Andersson U, et al. (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565-70.
-
(2000)
J. Exp. Med
, vol.192
, pp. 565-570
-
-
Andersson, U.1
-
14
-
-
0141750710
-
High mobility group 1 B-box mediates activation of human endothelium
-
Treutiger CJ, et al. (2003) High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254:375-85.
-
(2003)
J. Intern. Med
, vol.254
, pp. 375-385
-
-
Treutiger, C.J.1
-
15
-
-
19944431800
-
RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand
-
Kokkola R, et al. (2005) RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61:1-9.
-
(2005)
J. Immunol
, vol.61
, pp. 1-9
-
-
Kokkola, R.1
-
16
-
-
33645461206
-
High mobility group box 1 protein interacts with multiple Toll-like receptors
-
Park JS, et al. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 290:C917-24.
-
(2006)
Am. J. Physiol. Cell Physiol
, vol.290
-
-
Park, J.S.1
-
17
-
-
33746731651
-
HMGB1 signals through tolllike receptor (TLR) 4 and TLR2
-
Yu M, et al. (2006) HMGB1 signals through tolllike receptor (TLR) 4 and TLR2. Shock 26:174-9.
-
(2006)
Shock
, vol.26
, pp. 174-179
-
-
Yu, M.1
-
18
-
-
0036822347
-
High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis
-
Kokkola R, et al. (2002) High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum. 46:2598-603.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2598-2603
-
-
Kokkola, R.1
-
19
-
-
0037637564
-
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis
-
Pullerits R, et al. (2003) High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum. 48:1693-700.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 1693-1700
-
-
Pullerits, R.1
-
20
-
-
9144241208
-
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
-
Yang H, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 101:296-301.
-
(2004)
Proc. Natl. Acad. Sci. U. S. A
, vol.101
, pp. 296-301
-
-
Yang, H.1
-
21
-
-
0038681182
-
Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity
-
Kokkola R, et al. (2003) Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48:2052-8.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2052-2058
-
-
Kokkola, R.1
-
22
-
-
20144380566
-
Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock
-
Sunden-Cullberg J, et al. (2005) Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 33:564-73.
-
(2005)
Crit. Care Med
, vol.33
, pp. 564-573
-
-
Sunden-Cullberg, J.1
-
23
-
-
27844506606
-
Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation
-
Hatada T, et al. (2005) Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb. Haemost. 94:975-9.
-
(2005)
Thromb. Haemost
, vol.94
, pp. 975-979
-
-
Hatada, T.1
-
24
-
-
34250620898
-
Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis
-
Goldstein RS, et al. (2007) Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 13:210-5.
-
(2007)
Mol. Med
, vol.13
, pp. 210-215
-
-
Goldstein, R.S.1
-
25
-
-
41649101423
-
High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)
-
Bruchfeld A, et al. (2008) High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD). Mol. Med. 14:109-15.
-
(2008)
Mol. Med
, vol.14
, pp. 109-115
-
-
Bruchfeld, A.1
-
26
-
-
0033574249
-
A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation: Modification of Diet in Renal Disease Study Group
-
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 130:461-70.
-
(1999)
Ann. Intern. Med
, vol.130
, pp. 461-470
-
-
Levey, A.S.1
Bosch, J.P.2
Lewis, J.B.3
Greene, T.4
Rogers, N.5
Roth, D.6
-
27
-
-
77957672480
-
Protective targeting of HMGB1 in a spontaneous arthritis model
-
Ostberg T, et al. (2010) Protective targeting of HMGB1 in a spontaneous arthritis model. Arthritis Rheum. 62:2963-72.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2963-2972
-
-
Ostberg, T.1
-
28
-
-
0037380194
-
Outcome of ANCAassociated renal vasculitis: A 5-year retrospective study
-
Booth AD, et al. (2003) Outcome of ANCAassociated renal vasculitis: a 5-year retrospective study. Am. J. Kidney Dis. 41:776-84.
-
(2003)
Am. J. Kidney Dis
, vol.41
, pp. 776-784
-
-
Booth, A.D.1
-
29
-
-
27644437166
-
Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis
-
Hogan SL, et al. (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann. Intern. Med. 143:621-31.
-
(2005)
Ann. Intern. Med
, vol.143
, pp. 621-631
-
-
Hogan, S.L.1
-
30
-
-
31544480105
-
IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis
-
Hewins P, et al. (2006) IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int. 69:605-15.
-
(2006)
Kidney Int
, vol.69
, pp. 605-615
-
-
Hewins, P.1
-
31
-
-
42549119565
-
Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients: A prospective clinical study
-
Sundberg E, et al. (2008) Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients: a prospective clinical study. Arthritis Res. Ther. 10:R33.
-
(2008)
Arthritis Res. Ther
, vol.10
-
-
Sundberg, E.1
-
32
-
-
12544253745
-
Etanercept plus standard therapy for Wegener's granulomatosis
-
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
-
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. (2005) Etanercept plus standard therapy for Wegener's granulomatosis. N. Engl. J. Med. 352:351-61.
-
(2005)
N. Engl. J. Med
, vol.352
, pp. 351-361
-
-
-
33
-
-
77954566533
-
High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy
-
Oyama Y, et al. (2010) High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy. Lab. Invest. 90:853-66.
-
(2010)
Lab. Invest
, vol.90
, pp. 853-866
-
-
Oyama, Y.1
-
34
-
-
42549121715
-
High mobility group box chromosomal protein 1 in patients with renal diseases
-
Sato F, et al. (2008) High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron. Clin. Pract. 108:c194-201.
-
(2008)
Nephron. Clin. Pract
, vol.108
-
-
Sato, F.1
-
35
-
-
77957286579
-
Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCAassociated vasculitis
-
Wibisono D, et al. (2010) Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCAassociated vasculitis. Ann. Rheum. Dis. 69:1888-9.
-
(2010)
Ann. Rheum. Dis
, vol.69
, pp. 1888-1889
-
-
Wibisono, D.1
-
36
-
-
33845880868
-
Factors masking HMGB1 in human serum and plasma
-
Urbonaviciute V, Fürnrohr BG, Weber C, Haslbeck M, Wilhelm S, Herrmann M, Voll RE. (2007) Factors masking HMGB1 in human serum and plasma. J. Leukoc. Biol. 81:67-74.
-
(2007)
J. Leukoc. Biol
, vol.81
, pp. 67-74
-
-
Urbonaviciute, V.1
Fürnrohr, B.G.2
Weber, C.3
Haslbeck, M.4
Wilhelm, S.5
Herrmann, M.6
Voll, R.E.7
-
37
-
-
46849114754
-
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: A systematic review by the European League Against Rheumatism systemic vasculitis task force
-
Mukhtyar C, et al. (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann. Rheum. Dis. 67:1004-10.
-
(2008)
Ann. Rheum. Dis
, vol.67
, pp. 1004-1010
-
-
Mukhtyar, C.1
|